Home

Retragere lega In dungi cine ia votubia Taxă intern casnică

Addex Therapeutics Ltd
Addex Therapeutics Ltd

Cell signaling in cutaneous T‐cell lymphoma microenvironment: promising  targets for molecular‐specific treatment - Rendón‐Serna - 2021 -  International Journal of Dermatology - Wiley Online Library
Cell signaling in cutaneous T‐cell lymphoma microenvironment: promising targets for molecular‐specific treatment - Rendón‐Serna - 2021 - International Journal of Dermatology - Wiley Online Library

Reimbursement of orphan drugs in Belgium: what (else) matters? – topic of  research paper in Clinical medicine. Download scholarly article PDF and  read for free on CyberLeninka open science hub.
Reimbursement of orphan drugs in Belgium: what (else) matters? – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.

Everolimus and its role in hormone-resistant and trastuzumab-resistant  metastatic breast cancer | Future Oncology
Everolimus and its role in hormone-resistant and trastuzumab-resistant metastatic breast cancer | Future Oncology

wfiiJiUI_
wfiiJiUI_

immunosuppressant | New Drug Approvals
immunosuppressant | New Drug Approvals

immunosuppressant | New Drug Approvals
immunosuppressant | New Drug Approvals

Novartis presenta Votubia® como una alternativa eficaz a la cirugía para  pacientes con esclerosis tuberosa - Farmaconsejos
Novartis presenta Votubia® como una alternativa eficaz a la cirugía para pacientes con esclerosis tuberosa - Farmaconsejos

Everolimús (votubia®) en angiomiolipoma renal en pacients amb complex  d'esclerosi
Everolimús (votubia®) en angiomiolipoma renal en pacients amb complex d'esclerosi

Assessment report
Assessment report

Adenoid Cystic Carcinoma disease: Malacards - Research Articles, Drugs,  Genes, Clinical Trials
Adenoid Cystic Carcinoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

IJMS | Free Full-Text | PI3K/mTOR Pathway Inhibition: Opportunities in  Oncology and Rare Genetic Diseases | HTML
IJMS | Free Full-Text | PI3K/mTOR Pathway Inhibition: Opportunities in Oncology and Rare Genetic Diseases | HTML

PDF) Psychobehavioural and Cognitive Adverse Events of Anti-Seizure  Medications for the Treatment of Developmental and Epileptic  Encephalopathies
PDF) Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies

Cell signaling in cutaneous T‐cell lymphoma microenvironment: promising  targets for molecular‐specific treatment - Rendón‐Serna - 2021 -  International Journal of Dermatology - Wiley Online Library
Cell signaling in cutaneous T‐cell lymphoma microenvironment: promising targets for molecular‐specific treatment - Rendón‐Serna - 2021 - International Journal of Dermatology - Wiley Online Library

wfiiJiUI_
wfiiJiUI_

Elucidation of the mTOR Pathway and Therapeutic Applications in Dermatology  | Actas Dermo-Sifiliográficas
Elucidation of the mTOR Pathway and Therapeutic Applications in Dermatology | Actas Dermo-Sifiliográficas

wfiiJiUI_
wfiiJiUI_

Assessment report
Assessment report

Assessment report
Assessment report

Sezary's Disease disease: Malacards - Research Articles, Drugs, Genes,  Clinical Trials
Sezary's Disease disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Votubia, INN-everolimus
Votubia, INN-everolimus

Everolimus and its role in hormone-resistant and trastuzumab-resistant  metastatic breast cancer | Future Oncology
Everolimus and its role in hormone-resistant and trastuzumab-resistant metastatic breast cancer | Future Oncology

wfiiJiUI_
wfiiJiUI_

IJMS | Free Full-Text | PI3K/mTOR Pathway Inhibition: Opportunities in  Oncology and Rare Genetic Diseases | HTML
IJMS | Free Full-Text | PI3K/mTOR Pathway Inhibition: Opportunities in Oncology and Rare Genetic Diseases | HTML

PDF) Impact of orphan drugs on Latvian budget
PDF) Impact of orphan drugs on Latvian budget

Full article: mTOR dysregulation and tuberous sclerosis-related epilepsy
Full article: mTOR dysregulation and tuberous sclerosis-related epilepsy